Parkside Financial Bank & Trust - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 155 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$2,996
+68.3%
140
+218.2%
0.00%
Q1 2023$1,780
-13.0%
440.0%0.00%
-100.0%
Q4 2022$2,047
-31.8%
44
-25.4%
0.00%0.0%
Q3 2022$3,00059
+2850.0%
0.00%
Q2 2022$0
-100.0%
2
-96.7%
0.00%
-100.0%
Q1 2022$4,000
-20.0%
61
-7.6%
0.00%0.0%
Q4 2021$5,000
+25.0%
660.0%0.00%0.0%
Q3 2021$4,000
+33.3%
66
-2.9%
0.00%0.0%
Q2 2021$3,0000.0%68
+9.7%
0.00%0.0%
Q1 2021$3,000
+200.0%
62
+129.6%
0.00%
Q4 2020$1,000
-50.0%
27
-35.7%
0.00%
-100.0%
Q3 2020$2,0000.0%420.0%0.00%0.0%
Q2 2020$2,0000.0%420.0%0.00%0.0%
Q1 2020$2,000
+100.0%
42
+121.1%
0.00%
Q4 2019$1,000
-50.0%
19
-26.9%
0.00%
-100.0%
Q3 2019$2,0000.0%260.0%0.00%0.0%
Q2 2019$2,0000.0%260.0%0.00%0.0%
Q1 2019$2,000
+100.0%
26
+100.0%
0.00%
Q4 2018$1,0000.0%130.0%0.00%
Q3 2018$1,000
-50.0%
130.0%0.00%
-100.0%
Q2 2018$2,000
+100.0%
130.0%0.00%
Q1 2018$1,0000.0%130.0%0.00%
Q4 2017$1,0000.0%130.0%0.00%
Q3 2017$1,000130.0%0.00%
Q2 2017$0130.0%0.00%
Q1 2017$0130.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,599,109$63,277,0008.68%
SENZAR ASSET MANAGEMENT, LLC 566,903$22,432,0006.58%
Sarissa Capital Management LP 105,000$4,155,0001.60%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 136,637$5,407,0001.41%
RA Capital Management 250,000$9,893,0001.17%
BENNETT LAWRENCE MANAGEMENT L L C/NY 110,515$4,373,0000.99%
Ghost Tree Capital, LLC 35,000$1,385,0000.75%
WALL STREET ASSOCIATES 159,100$6,296,0000.65%
BAILARD, INC. 91,500$3,621,0000.56%
EAM Investors, LLC 62,768$2,484,0000.50%
View complete list of ENANTA PHARMACEUTICALS INC shareholders